Name: ASTH Income Statement - Astrana Health Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

ASTH - Astrana Health, Inc.

USD | NASDAQ | Industrials

ASTH Income Statement - Astrana Health Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	965.1	950.5	956.0	654.8	620.4	665.2	478.7	486.3	404.4	353.0	348.2	348.2	337.2	294.2	317.0	269.7

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011
Revenues
Revenues	3,526.5	3,181.8	2,034.5	1,386.7	1,144.2	773.9	687.2	560.6	519.9	356.4	305.9	33.0	10.5	7.8	5.1	3.9
Cost of Revenue	-	-	-	-	-	596.1	539.2	467.8	361.1	273.5	254.8	22.1	9.1	6.3	4.1	3.3
Gross Profit	-	-	-	-	-	177.8	148.0	92.8	158.8	82.9	51.2	10.9	1.4	1.5	1.0	0.6
Operating Expenses
Research & Development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income
Operating Income	86.5	78.5	89.4	84.6	104.3	98.2	80.5	32.4	88.4	35.1	11.7	(0.7)	(3.9)	(2.1)
Non-Operating
Interest Income	13.7	12.2	14.5	14.2	2.0	1.6	2.8	2.0	1.3	1.0	0.5	-	-	-	-	-
Tax & Net
Income Tax Expense	18.7	15.5	30.9	32.0	40.9	31.7	56.3	8.2	22.4	3.9	8.8	0.2	0.0	0.0	0.0
Per Share
EPS Basic	0.62	0.46	0.91	1.30	1.00	1.57	1.03	0.41	0.33	1.01	0.46	-	-	-	-	-
Supplementary Data
EBITDA	-	124.3	117.3	102.4	121.8	115.7	98.9	50.7	107.7	54.2	29.8	(0.4)	(3.9)	(2.1)	(0.4)	0.0

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	61.7	60.2	62.4	50.7	43.9	41.6	37.8	36.0	38.7	37.9	29.4	24.1	21.2	24.4	21.4	19.9	11.9
Depreciation & Amortization	15.5	-	-	-	6.8	-	-	-	5.1	-	-	-	4.3	-	-	-
Amortization of Intangibles	13.9	14.0	14.2	6.2	6.3	5.1	6.7	6.9	6.9	3.2	3.2	3.3	3.0	3.1	3.4	3.5	3.7
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	936.6	932.1	936.8	634.5	599.8	664.5	450.3	456.2	374.2	356.9	309.1	321.2	314.9	281.6	266.9	254.3

Operating Income
Operating Income	28.5	18.4	19.2	20.3	20.6	0.7	28.4	30.1	30.1	(3.9)	39.1	27.0	22.4	12.6	50.1	15.4	26.2	2.3	53.2	21.0	21.8	25.9	37.4	12.9	4.4	10.9	10.1	14.7	(3.3)	2.0	56.6	7.1	22.7	(5.8)	21.3	4.1	15.7	(1.7)	(2.2)	(1.8)

Tax & Net
Income Tax Expense	6.6	0.9	4.6	6.6	3.4	5.9	7.8	10.0	7.1	1.0	10.0	14.0	6.9	11.3	17.4	5.4	6.8	0.1	(0.1)	24.9	6.8	12.1	10.8	31.9	1.6	1.7	3.7	4.2	(1.4)	(1.0)	14.6	1.5	7.2	(12.6)	7.9	0.7	7.9	0.1	(0.2)	(0.0)
Net Income From Continuing Ops	13.1	6.6	1.1	10.2	6.2	(7.8)	19.0	21.9	16.9	(0.1)	28.0	17.5	12.5	(0.9)	23.9	11.3	11.5
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	13.1	6.6	1.1	10.2	6.2	(7.8)	19.0	21.9	16.9	(0.1)	28.0	17.5	12.5	(0.9)	23.9	11.3	11.5
Net Income Attributable To Parent	14.4	6.0	0.4	9.4	6.7	(7.0)	16.1	19.2	14.8	12.4	22.1	13.2	13.1	(3.7)	23.2	12.0
Less: Minority Interest	(1.3)	0.6	0.7	0.8	(0.5)	(0.8)	2.9	2.7	2.0	(12.5)	5.9	4.3	(0.6)	2.8	0.7	(0.7)	(2.3)
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	14.4	6.0	0.4	9.4	6.7	(7.0)	16.1	19.2	14.8	12.4	22.1	13.2	13.1	(3.7)	23.2

Per Share
EPS Basic	0.30	-	0.01	0.19	0.14	-	0.34	0.40	0.31	-	0.47	0.28	0.28	-	0.52	0.27	0.31	-	0.77	0.29	0.31	-	0.46	0.20	0.11	-	0.11	0.10	0.00	-	0.28	0.08	0.07	-	0.22	0.08	0.17	-	-	-
EPS Diluted	0.29	-	0.01	0.19	0.14	-	0.33	0.40	0.31	-	0.47	0.28	0.28	-	0.50	0.26	0.30	-
Shares Basic	48.9	-	49.2	49.2	48.5	-	47.7	47.6	47.3	-	46.5	46.5	46.6	-	44.9	44.9	44.7	-
Shares Diluted	49.1	-	49.5	49.5	48.9	-	48.2	48.0	47.7	-	46.9	46.8	47.0	-	46.2	46.0	46.0	-

Supplementary Data
EBITDA	44.0	-	-	-	27.4	-	-	-	35.2	-	-	-	26.7	-	-	-	30.6	-	-	-	26.0	-	-	-	9.1	15.4	15.0	19.2	1.1	6.5	61.4	12.1	27.8	(1.2)	26.0	8.9	20.5	(1.5)	(2.0)	(1.6)
EBIT	28.5	18.4	19.2	20.3	20.6	0.7	28.4	30.1	30.1	(3.9)	39.1	27.0	22.4	12.6	50.1	15.4	26.2	2.3	53.2

Non-Operating
Interest Income	3.8	4.0	3.5	2.3	2.3	3.2	3.8	3.5	4.0	4.6	3.3	3.3	3.0	1.3	0.2	0.4	0.0	0.2	0.4	0.6	0.3	0.3	0.8	0.9	0.9	0.7	0.5	0.5	0.3	0.1	0.4	0.5	0.3	0.4	0.2	0.2	0.2	-	-	-
Interest Expense	16.1	17.5	17.7	7.4	7.3	8.1	8.9	8.6	7.6	5.4	3.8	3.6	3.3	2.6	2.4	1.9	1.1	1.1
Income From Equity Investments	1.7	1.2	1.0	0.4	(0.9)	1.6	1.4	0.9	0.6	2.5	(2.1)	2.7	2.5	1.2	1.5	1.5
Other Non-Operating Income	(8.8)	(10.9)	(13.5)	(3.5)	(11.0)	(2.6)	(1.6)	1.8	(6.1)	4.8	(1.1)	4.5	(3.0)	(2.1)	(8.8)	1.2	(7.9)
Pre-Tax Income	19.7	7.5	5.7	16.8	9.6	(1.9)	26.8	31.9	24.0	0.9	38.0	31.5	19.4	10.5	41.3	16.6	18.3